Abstract
Tendinopathies are significative among musculoskeletal injuries in both humans and animals. The treatments used in this disease are not very effective in producing scar tissue of similar quality to the previous one and in reducing the rates of recurrences. New therapies are being tested with the aim of achieving better results such as the use of mesenchymal stem cells (MSCs), bioinks used…